As expected, the FDA has moved quickly to grant emergency use authorisation (EUA) to two new-generation COVID-19 mRNA vaccines from Pfizer/BioNTech and Moderna, both targeting the new Omicron ...

Stock markets around the world have fallen after the boss of Moderna cast doubts on the effectiveness of vaccines against the new Omicron Covid variant. Stephane Bancel told the Financial Times he ...

COVID-19 (omicron JN.1) vaccine is under clinical development by Moderna and currently in Pre-Registration for Coronavirus Disease 2019 (COVID-19).

The UK has become the first country in the world to authorise an updated COVID-19 booster vaccine directed at the Omicron variant, giving a green light to Moderna's mRNA-1273.214 shot.

Stock-plunging mRNA vaccine maker, already in bed with feds on vaccine royalties, says booster not "causally" related without ...

US company Moderna is planning to begin trials of its own Omicron-specific shot soon. Oxford University and AstraZeneca have also started working on a new version of their vaccine. Vaccine ...

1 Omicron subvariant, which was prevalent last winter, and the original novel coronavirus strain that the previous vaccines were designed to fight. Pfizer Inc. and Moderna Inc. have each applied ...

Both Moderna and Pfizer-BioNTech manufacture the ... "At the height of the Omicron wave, we still saw a lot of children being ...

1, an Omicron subvariant, and an early strain of the novel coronavirus. Pfizer Inc. and Moderna Inc. have been developing their versions of the bivalent vaccine. Trial runs reportedly showed that ...

The XBB.1.5 subvariant — nicknamed ‘Kraken’ — is arguably the most genetically rich and most transmissible SARS-CoV-2 omicron subvariant yet. News Wrap: Russia shells Bakhmut in eastern ...